Zymeworks is a global biotechnology company managing a portfolio of licensed healthcare assets and developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease. The Company’s asset and royalty aggregation strategy focuses on optimizing positive future cash flows from an emerging portfolio of licensed products such as Ziihera® (zanidatamab-hrii) and other licensed products and product candidates such as pasritamig. In addition, Zymeworks is also building a portfolio of healthcare assets that can generate strong cash flows, while supporting the early-stage development of innovative medicines.We are a global company headquartered in Vancouver BC, with operations in Bellevue WA, Dublin IRE, and Singapore.
About the Position
We are currently seeking a Co-op Student to join our In Vitro Pharmacology team, a part of Multispecific Antibody Therapeutics. The successful candidate will be responsible for supporting experimental tasks related to therapeutics research. The Co-op Student will be involved in designing and executing complex immunological assays to interrogate new biology and fuel the development of innovative biotherapeutics.
This role will be located in Vancouver, BC and is full-time onsite. The hourly wage for this co-op position is $21.00 CAD.
What You'll Do
What You'll Bring
Total Rewards
Zymeworks’ employees are passionate, engaged and extremely motivated to succeed. We are excited by the cutting-edge science and technology, the endless possibilities this union holds and the sheer opportunity to be a part of something big.
As a Co-op Student, you’ll get to work directly with the teams to learn and contribute to creating the best-in-class therapeutics. Our Co-op Program is designed to challenge students to think critically by actively participating in projects, and to develop professionally and personally.
Our competitive program makes your time at Zymeworks worthwhile.
All qualified applicants will receive consideration for employment without regard to race, colour, religion, sex, sexual orientation, gender identity, national origin or disability.
NOTE TO AGENCIES: Zymeworks values our relationships with our recruiting partners. We only accept resumes from those partners who have been contracted with us. Zymeworks is not responsible for any fees related to resumes that are unsolicited or are received without contract.

Zymeworks is a clinical-stage biotechnology company unlocking new possibilities in cancer and autoimmune disease treatment. Our mission is to make a meaningful difference in the lives of patients by advancing a growing pipeline of next-generation antibody therapeutics, including T cell engagers and antibody-drug conjugates (ADCs).
Our lead asset, zanidatamab—a HER2-targeted bispecific antibody— is partnered with Jazz Pharmaceuticals and BeOne Medicines and is approved in the U.S. and China for previously-treated, unresectable or metastatic HER2-positive (IHC 3+) biliary tract cancer. Zanidatamab is also being evaluated in multiple global clinical trials as a potential best-in-class treatment for patients with multiple HER2-expressing cancers. We’re also rapidly advancing a robust pipeline of wholly-owned ADC and multispecific programs designed to target areas of significant unmet medical need.
With integrated R&D capabilities and a proven track record of scientific innovation and collaboration, we’re building strategic partnerships and a culture where passionate people can make an impact.
Join us as we engineer what’s next in biotherapeutics.